Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SBRX10 is a plant-based drug candidate developed by Stramsen Biotech, a Texas-based biopharmaceutical company, for the relief of constipation. The drug is part of the company's SBRX series, which utilizes a proprietary database of medicinal plants to develop natural therapeutics for various conditions, including gastrointestinal disorders. Stramsen Biotech focuses on a natural plant-based approach to drug discovery, leveraging botanical compounds to address unmet medical needs. While SBRX10 is part of a pipeline that includes candidates in early-stage clinical trials, its specific active botanical ingredients, molecular targets, and precise clinical phase have not been publicly disclosed.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on SBRX10.